| Overview |
| bs-2481R-Cy5 |
| CCL16/HCC-4 Polyclonal Antibody, Cy5 Conjugated |
| IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CCL16 |
| 24-120/120 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 6360 |
| Secreted |
| C-C mot chemokine 16; chemokine C-C mot ligand 16; CCL16; CKb12; HCC4; IL10 inducible chemokine; ILINCK; LCC1; Liver CC chemokine 1 precursor; Liver expressed chemokine; LMC; Monotactin 1; Mtn1; NCC4; New CC chemokine 4; SCYA16; SCYL4; Small inducible cytokine A16 precursor; Small inducible cytokine subfamily A Cys Cys member 16; Small-inducible cytokine A16. CCL16_HUMAN |
| LEC (liver expressed cytokine) displays chemotactic activity for lymphocytes and monocytes but not for neutrophils. It also shows a potent myelosuppressive activity and suppresses proliferation of myeloid progenitor cells. Its expression is upregulated by IL10. |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz